Not Your Average Growth Hormone Secretagogue

Let’s cut to the chase. You’re here because you know what peptides are and you’re looking for a serious, synergistic blend. This isn’t a single-compound experiment. This is a precision-engineered stack combining Tesamorelin, CJC-1295 (Mod GRF 1-29), and Ipamorelin into a single 12mg vial. The goal? To target the somatotroph cells in the pituitary from multiple, complementary angles for a potentiated release of endogenous growth hormone. Think of it as a full-spectrum approach, not a single key in a lock.

Most blends try to sell you on hype. We’re giving you the biochemistry. Tesamorelin and CJC-1295 are both Growth Hormone-Releasing Hormone (GHRH) analogs. They bind to the GHRH receptor, signaling for GH production and release. Ipamorelin works on a different pathway—the ghrelin or Growth Hormone Secretagogue Receptor (GHSR). By activating both primary release pathways simultaneously, this blend aims to produce a more robust and physiologically balanced GH pulse than any single peptide could. It’s about synergy, not just addition.

Breakdown of the Components: What You’re Actually Getting

You need to know what’s in your vial. Here’s the spec sheet.

• Tesamorelin: A 44-amino acid GHRH analog with specific modifications (trans-3-hexenoic acid at the C-terminus) to resist enzymatic degradation. It’s not just GHRH; it’s a stabilized, potent version designed for a longer half-life and consistent receptor activation. Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S.
• CJC-1295 (Mod GRF 1-29): This is the “no DAC” version, meaning it doesn’t have a Drug Affinity Complex for extreme half-life extension. What you get is Mod GRF 1-29—a 29-amino acid sequence with four key substitutions (D-Ala, Lys, D-Phe, N-methylglycine) that dramatically increase its stability and binding affinity to the GHRH receptor without creating an unnaturally long, flat release profile. It’s for pulse, not constant flood. Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂.
• Ipamorelin: A selective GHSR agonist. Its claim to fame is its specificity; it triggers GH release without significant spikes in cortisol, prolactin, or ACTH that are common with older secretagogues. It’s a clean, focused signal on the ghrelin receptor pathway. Sequence: Aib-His-D-2Nal-D-Phe-Lys. Molecular Formula: C₃₈H₄₉N₉O₅.

We combine these at a precise ratio in a single 12mg blend. This eliminates the need to reconstitute and inject multiple separate vials, reducing handling error and ensuring the intended synergistic dose is delivered every time.

The Research Rationale: Why This Tri-Blend Works

The data behind each component informs why stacking them makes sense. This isn’t theoretical; it’s based on observed mechanisms.

On GH/IGF-1 Output: Individually, these peptides have demonstrated significant impacts in experimental models. Tesamorelin exposure has been associated with a 69% increase in total GH AUC and a 122% rise in IGF-1 levels. A CJC-1295 analog showed potential to enhance GH release by 70-107% over 12 hours with a 28% increase in IGF-1. Ipamorelin has been shown to elevate GH secretion to levels approximately 60 times higher than placebo. The logic of the blend is to combine these effects multiplicatively, not additively, by saturating both release pathways.

On Body Composition: The research points to targeted effects. Tesamorelin studies note a pronounced impact on visceral adiposity, with one 52-week review showing a mean reduction of -17.5% in visceral fat and improvements in triglyceride/cholesterol profiles. In muscle tissue, Tesamorelin has been correlated with improvements in muscle density and volume, along with a reduction in intramuscular fat. CJC-1295 data has shown support for increased lean mass and skeletal muscle growth. Ipamorelin research suggests a potential to restore nitrogen balance and reduce nitrogen wasting, creating a more anabolic environment.

The Appetite Note: Be aware. Ipamorelin acts on the ghrelin receptor. In some experimental models, this activation has been associated with an increase in food intake and body weight. This is a direct pharmacological effect of the pathway, not a side effect. It’s part of the mechanism to understand in your research planning.

PeptideLabsDirect Difference: No Smoke, Just Specs

We’re not a supplement company. We’re a direct supplier for research purposes. Here’s what that means for you:

• <